Exchange Factor EFA6R Requires C-terminal Targeting to the Plasma Membrane to Promote Cytoskeletal Rearrangement through the Activation of ADP-ribosylation Factor 6 (ARF6)Venkateswarlu Kanamarlapudi(Swansea University)Journal of Biological ChemistryOctober 9, 201410.1074/jbc.m113.534156Cited by 26SaveCiteExport RISWatch citationsRelated PapersTargeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide|Cancers|2023|7